Press release

Péter Ferdinandy, MD, PhD, MBA, Founder & CEO of Pharmahungary Group has been noticed as “Highly Cited Researcher” for the 4th time.

Further information here.

2021.11.30.

The main purpose of HBA is to strengthen the position of biotechnology as a strategic industry in Hungary.

In each year HBA organizes special forums which provide opportunities for personal contacts between researchers, investors, companies and government decision-makers.

The forum will continue to bring together the academic, business and public sectors in order to create more efficient and more successful collaborations not only at a national, but also at an international level.

szecskay
bay
77elektronika_logo_2013-jpg
soneas-logo-300x100
creativelaboratory
richter
oncompass
seqomics
softflow
ud-genomed
evonik
tomtec
targetex_bioscience
lipidart
3dhistech
convincive
worldcourier
avicor
biotalentumconsulting1
egis_szlogenes_en-rgb
thalesnanologonew2
logo_hungarotrial
cominnex
humeltis-logo-uj
pharmahungary
hyd
tomtec
abiomics
solvo
amgen
pannonpharm
airmax-f-logo_voros-alap-copy
omixon1
cyclolab
tfs_logo_cmyk_ez